Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
Go back to Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X| (AMEX: MBCOF) | Delayed: 0.11 +0.01 (10.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.10 | 52 Week High | $ | |||
| Open | $0.11 | 52 Week Low | $ | |||
| Day High | $0.11 | P/E | N/A | |||
| Day Low | $0.11 | EPS | $ | |||
| Volume | 5,000 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 244.25 +3.49 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.76 | 52 Week High | $13.61 | |||
| Open | $242.06 | 52 Week Low | $7.40 | |||
| Day High | $244.44 | P/E | 381.64 | |||
| Day Low | $235.96 | EPS | $0.64 | |||
| Volume | 23,592,430 | |||||
